It looks like your browser is not up to date.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

3i Group Plc (III) Ordinary 73 19/22p

Sell:1,222.00p Buy:1,223.00p 0 Change: No change
FTSE 100:0.15%
Market closed Prices as at close on 17 May 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1,222.00p
Buy:1,223.00p
Change: No change
Market closed Prices as at close on 17 May 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1,222.00p
Buy:1,223.00p
Change: No change
Market closed Prices as at close on 17 May 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Objective

3i is an investment company which aims to provide its shareholders with quoted access to private equity and infrastructure returns. Currently, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.
Security Weight
Action SA 40.92%
3i Infrastructure plc Ord NPV 7.46%
Scandlines 4.33%
Cirtec Medical 3.59%
Evernex 2.84%
Royal Sanders 2.82%
Hans Anders 2.61%
WP AG 2.49%
Havea 2.43%
Tato 2.37%
Sector Weight
Technology 40.92%
Consumer Cyclical 5.09%
Country Weight
Poland 40.92%
Austria 2.49%
United Kingdom 1.91%
Netherlands 1.35%
Denmark 1.25%

Fee Structure

Management fee of between 1.2% and 1.4% on a tiered basis. Performance fee of 20% of returns above a hurdle of 8% of the growth in NAV per share with a deferral and clawback mechanism in the event of subsequent performance below the hurdle.

Dividend Policy

The Group aims to maintain or grow the dividend each year.

ASSET SPLIT

Total number of holdings: 31.

Trust Manager

Not currently available for this investment trust.

Manager Bio

Not currently available for this investment trust.

Board Of Directors

Simon ThompsonChairman, Simon Borrows, Caroline Banszky, Coline McConville, Stephen Daintith, Julia Wilson, Alexandra Schaapveld, David Hutchison

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.